Video

Institutional Perspectives: Cardiovascular Risk Management, Chaired By Manesh Patel, MD

Author(s):

In this series of HCPLive® State of the Science, 4 experts discuss knowledge and treatment in the cardiovascular risk management space.

On June 23, Manesh Patel, MD, Chief of Cardiology and Clinical Pharmacology, Duke University School of Medicine, led the HCPLive® State of the Science Event "Institutional Perspectives in Cardiology: Cardiovascular Risk Management."

Patel was joined by his colleagues at the Duke University School of Medicine, including Schuyler Jones, MD, Tracy Wang, MD, and Christopher Granger, MD, to discuss recent trials, identify risk, and treatment options in the cardiovascular risk management space.

The conversation surrounded the following topics:

  • CAD/PAD: Identifying Risk & Summary of Recent Clinical Trials
  • Extended Thromboprophylaxis: What Do We Know About Scoring, Risk and Contemporary Trials?
  • Atrial Fibrillation: What Have We Learned About NOACs in Special Populations?
  • Putting This All Together: Treatment Pyramid
Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.